Novavax

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.

About NVAX

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. 

CEO
Stanley C. Erck
CEOStanley C. Erck
Employees
1,541
Employees1,541
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
1,541
Employees1,541

NVAX Key Statistics

Market cap
1.30B
Market cap1.30B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
4.00M
Average volume4.00M
High today
High today
Low today
Low today
Open price
$16.79
Open price$16.79
Volume
1.50K
Volume1.50K
52 Week high
$236.50
52 Week high$236.50
52 Week low
$16.00
52 Week low$16.00

NVAX News

Yahoo Finance 3d
Investors Heavily Search Novavax, Inc.: Here is What You Need to Know - Yahoo Finance

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influ...

Investors Heavily Search Novavax, Inc.: Here is What You Need to Know - Yahoo Finance
Benzinga 5d
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday - Agora, AGBA Acq - Benzinga

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session...

Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday - Agora, AGBA Acq - Benzinga
Investor's Business Daily 6d
Is Novavax Stock A Buy On Its Massive Sales Beat Despite Unexpected Losses?

Novavax (NVAX) quadrupled its sales in the third quarter, though delivered an unexpected per-share loss — leading NVAX stock to pop after its earnings report....

Is Novavax Stock A Buy On Its Massive Sales Beat Despite Unexpected Losses?

Analyst ratings

43%

of 7 ratings
Buy
42.9%
Hold
28.6%
Sell
28.6%

NVAX Earnings

-$11.18
-$5.33
$0.51
$6.36
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 27, After Hours
ActualExpected Feb 27, After Hours

More NVAX News

Benzinga 6d
Novavax Terminates Agreement With GAVI Alliance For Sale Of Its COVID-19 Vaccines

Novavax Inc (NASDAQ: NVAX) delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of its COVID-19...

Novavax Terminates Agreement With GAVI Alliance For Sale Of Its COVID-19 Vaccines
Reuters 7d
UPDATE 1-Novavax ends COVID vaccine sale agreement with Gavi

(Adds details, background) Nov 21 (Reuters) - Novavax Inc said on Monday it had delivered a written notice to Gavi, the Vaccine Alliance, terminating with imme...

UPDATE 1-Novavax ends COVID vaccine sale agreement with Gavi
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.